Dr. Andrea Adams-Miller Warns That CDC-Reported Record Flu Activity Is Driving Stress and That Mental Health Support Is Critical Right Now

FINDLAY, OH - January 08, 2026 - PRESSADVANTAGE - Dr. Andrea Adams-Miller, an applied neuroscientist and executive ...

Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.